LIGAND PHARMACEUTICALS INC ($LGND)
Filing Information
| Accession Number | 0001950232-26-000003 |
|---|---|
| Form Type | 4 |
| Filing Date | Oct 6, 2026 |
| Document | View SEC Filing |
Transactions
8
Total Shares
5,680
Total Value
$1,538,117.67
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CLO&Secretary | Common Stock | โ | Oct 2, 2026 | Exercise/Conversion | 340 | $52.27 | $17,771.80 | 36,854 | Direct | โ | View Details | |
CLO&Secretary | Common Stock | โ | Oct 2, 2026 | Sale | 833 | $302.51 | $251,991.41 | 36,021 | Direct | โ | View Details | |
CLO&Secretary | Common Stock | โ | Oct 2, 2026 | Sale | 1,976 | $303.54 | $599,803.73 | 34,045 | Direct | โ | View Details | |
CLO&Secretary | Common Stock | โ | Oct 2, 2026 | Sale | 1,535 | $304.52 | $467,431.14 | 32,510 | Direct | โ | View Details | |
CLO&Secretary | Common Stock | โ | Oct 2, 2026 | Sale | 404 | $306.18 | $123,698.09 | 32,106 | Direct | โ | View Details | |
CLO&Secretary | Common Stock | โ | Oct 2, 2026 | Sale | 235 | $307.19 | $72,189.91 | 31,871 | Direct | โ | View Details | |
CLO&Secretary | Common Stock | โ | Oct 2, 2026 | Sale | 17 | $307.74 | $5,231.58 | 31,854 | Direct | โ | View Details | |
CLO&Secretary | Employee Stock Option (right to buy) | Derivative | Oct 2, 2026 | Exercise/Conversion | 340 | $0.00 | $0.00 | 29,104 | Direct | โ | View Details |